The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; BMS GmbH & Co. KG; MSD
Subcutaneous (SC) nivolumab (NIVO) vs intravenous (IV) NIVO in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Safety and patient-reported outcomes (PROs) of the randomized phase 3 CheckMate 67T trial.
 
Maria T. Bourlon
Leadership - BMS
Honoraria - BMS; Tecnofarma; Tecnofarma
Consulting or Advisory Role - Asofarma; Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Gilead Sciences; Janssen Oncology; Merck; MSD; MSD Oncology; Novartis; Novartis; Pfizer
Speakers' Bureau - Asofarma; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ferring; Ipsen; Janssen Oncology; Medicamenta; Merck; MSD Oncology; Pfizer; Tecnofarma
Research Funding - Janssen Oncology (Inst); Pfizer
Expert Testimony - Asofarma
Travel, Accommodations, Expenses - Asofarma; Bristol-Myers Squibb (Mexico); Janssen-Cilag; MSD Oncology; Pfizer
Other Relationship - Sanofi
 
Laurence Albiges
Consulting or Advisory Role - Astellas Pharma (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Ipsen; MSD; Pfizer
 
Matias Rodrigo Chacon
Honoraria - Novartis
 
Hernan Cutuli
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche
 
Jose Mauricio Mota
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen; Merck; Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; Janssen Oncology
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ipsen; Janssen Oncology; Merck; Pfizer; Zodiac Pharma
Expert Testimony - Astellas Pharma; Bayer
Travel, Accommodations, Expenses - Janssen Oncology; Zodiac Pharma
 
Ignacio Magri
No Relationships to Disclose
 
Mauricio Burotto
No Relationships to Disclose
 
Murilo Luz
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen; Medivation; Myovant Sciences; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Merck; Roche
 
Juliana Menezes
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
 
Eduardo Patricio Yanez Ruiz
Honoraria - Abbott Laboratories
Consulting or Advisory Role - Abbott Laboratories; Bristol-Myers Squibb; Merck Serono
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
Expert Testimony - Abbott Laboratories
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Marco Maruzzo
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Exelx; Janssen; Merck Serono; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Sergio Bracarda
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Serono; MSD Oncology; Pfizer
 
Dhanrajsinh Rathod
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Zhuoxin Yu
Patents, Royalties, Other Intellectual Property - Rutgers University (I)
 
Balmeet Gurm
Employment - Bristol-Myers Squibb
 
Matthew Dixon
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Saby George
Consulting or Advisory Role - AstraZeneca; AVEO; AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Merck; Novartis; Pfizer; QED Therapeutics; Sanofi; Seattle Genetics/Astellas
Research Funding - Agensys (Inst); Aravive (Inst); Aveo (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Gilead Sciences (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst); Surface Oncology (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Medarex; Sanofi